Furthermore, the proportion of proliferating tumor-infiltrated CD8+ T cells (Ki67+), but not CD4+ T cells, was significantly increased in tumor after administration of either OX40 antibodies (Figures 5C). This evidence concerns the gene CD4 and neoplasm.